STOCK TITAN

AmerisourceBergen Corporation - ABC STOCK NEWS

Welcome to our dedicated page for AmerisourceBergen Corporation news (Ticker: abc), a resource for investors and traders seeking the latest updates and insights on AmerisourceBergen Corporation stock.

Cencora, Inc. (NYSE: COR), formerly known as AmerisourceBergen Corporation, is a leading global pharmaceutical solutions organization dedicated to improving the lives of people and animals worldwide. With a unified identity and vision under the new name, Cencora connects pharmaceutical innovators, care providers, pharmacies, and patients to ensure the seamless and reliable delivery of vital therapies and healthcare products.

Headquartered in Conshohocken, Pennsylvania, Cencora boasts a comprehensive portfolio of services across the pharmaceutical value chain. The company is renowned for its robust pharmaceutical distribution network, specialty logistics, and biopharma services, ensuring medications reach their destinations efficiently and safely. Cencora's extensive reach is evidenced by its operations in over 50 countries, supported by a team of more than 46,000 dedicated employees.

Cencora's commitment to innovation is further highlighted through initiatives like Cencora Ventures, the company's corporate venture fund dedicated to fostering healthcare advancements. Additionally, the Cencora Impact Foundation underscores the company's dedication to social responsibility, with a recent $5 million donation to support global healthcare initiatives, including a significant grant to UNICEF Health Fund.

Financially, Cencora is a powerhouse with more than $200 billion in annual revenue, ranking #11 on the Fortune 500 and #24 on the Global Fortune 500. The company's strategic investments, such as the acquisition of OneOncology and PharmaLex, showcase its focus on expanding its specialty and global commercialization services. Cencora's recent name change reflects its bold vision and purpose-driven approach to creating healthier futures, unifying its global presence under one cohesive brand.

Rhea-AI Summary

AmerisourceBergen Corporation (NYSE: ABC) will release its Third Quarter Fiscal 2022 results on August 3, 2022, before market opening. A conference call will take place at 8:30 a.m. ET on the same day, featuring CEO Steven H. Collis and CFO James F. Cleary. The call will be accessible via webcast on the company's investor relations website. AmerisourceBergen ranks #10 on the Fortune 500, with annual revenues exceeding $200 billion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.46%
Tags
-
Rhea-AI Summary

Seefried Properties has begun construction on a new 80,053 square foot distribution facility in Mount Prospect, Illinois, strategically located near O'Hare Airport. This Class A facility will include features for freight-forwarding and air cargo warehousing. Within a week of breaking ground, World Courier Inc. has signed a lease for 34,011 square feet. With vacancy rates in Chicago at record lows, Seefried aims to expand its offerings in the Midwest, with 46,042 square feet still available for lease. The project showcases the company's ongoing commitment to developing industrial properties.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.23%
Tags
none
-
Rhea-AI Summary

AmerisourceBergen Corporation (NYSE: ABC) hosted an investor day in New York City, highlighting its strategy for sustainable growth in healthcare solutions. CEO Steven H. Collis emphasized the company’s role in pharmaceutical distribution and its investments in higher-margin services. The firm outlined five strategic imperatives aimed at enhancing operational efficiency and expanding its specialty services. For FY2022, it forecasted adjusted diluted EPS between $10.80 and $11.05, with adjusted operating income growth anticipated at 5-8%. The company also has a $1 billion share repurchase authorization.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.2%
Tags
none
Rhea-AI Summary

AmerisourceBergen Corporation (NYSE: ABC) reiterated its fiscal 2022 guidance, projecting adjusted diluted earnings per share in the range of $10.80 to $11.05. The Board authorized a $1.0 billion share repurchase program, which is independent of this guidance. The company's Investor Day is scheduled for June 1, 2022, focusing on strategic imperatives and ESG commitments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.09%
Tags
none
-
Rhea-AI Summary

AmerisourceBergen Corporation (NYSE: ABC) has announced the resumption of share repurchases, leveraging excess free cash flow as part of its disciplined capital allocation strategy. The company is committed to retaining its investment grade credit ratings while planning to pay down $2 billion in debt by March 2023, ahead of the two-year timeline following the acquisition of Alliance Healthcare in June 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.01%
Tags
none
-
Rhea-AI Summary

Walgreens Boots Alliance has sold 6.0 million shares of AmerisourceBergen Corporation for $900 million, reducing its stake from 28.1% to 25.2%. The proceeds will primarily be allocated for debt paydown and supporting strategic initiatives. Despite the sale, Walgreens maintains its long-term partnership with AmerisourceBergen, ensuring ongoing collaboration. This strategic move aims to optimize capital allocation and enhance the company's balance sheet, reflecting a commitment to shareholder value.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

AmerisourceBergen reported a 17.4% revenue increase year-over-year for Q2, reaching $57.7 billion. The company's GAAP diluted EPS was $2.59, up from $2.10 in the previous year. Adjusted diluted EPS rose 27.3% to $3.22. The firm has raised its adjusted diluted EPS guidance for fiscal 2022 to a range of $10.80 to $11.05.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4%
Tags
-
Rhea-AI Summary

AmerisourceBergen (ABC), Cardinal Health (CAH), and McKesson (MCK) have settled opioid-related claims with the Washington Attorney General, agreeing to pay up to $518 million. This payment resolves lawsuits filed by the state and its subdivisions, allowing for the dismissal of ongoing litigation. The settlement aligns with a previously announced agreement effective April 2, 2022, aimed at addressing a significant portion of opioid claims against the distributors. The companies dispute the allegations but see this as steps toward broader resolutions and relief for impacted communities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

AmerisourceBergen Corporation (NYSE: ABC) will announce its Q2 Fiscal 2022 results on May 4, 2022, before NYSE trading begins. A conference call led by CEO Steven H. Collis and CFO James F. Cleary will follow at 8:30 a.m. ET. Participants can join via webcast on the company's investor site or by phone, with replays available post-call. Additionally, AmerisourceBergen will host an Investor Day on June 1, 2022, in New York City. The company ranks #8 on the Fortune 500 with over $200 billion in annual revenue.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.2%
Tags
Rhea-AI Summary

Settlement Announcement: AmerisourceBergen (ABC), Cardinal Health (CAH), and McKesson (MCK) have reached an agreement to settle the majority of opioid lawsuits with participation from 46 of 49 eligible states and over 90% of litigating political subdivisions. The settlement totals approximately $19.5 billion to be distributed over 18 years, with individual contributions of $6.1 billion, $6.0 billion, and $7.4 billion from AmerisourceBergen, Cardinal Health, and McKesson, respectively. The agreement aims to provide relief to communities affected by the opioid crisis.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the market cap of AmerisourceBergen Corporation (abc)?

The market cap of AmerisourceBergen Corporation (abc) is approximately 36.1B.

What is Cencora, Inc.?

Cencora, Inc., formerly AmerisourceBergen Corporation, is a global pharmaceutical solutions organization focused on improving the lives of people and animals through secure, reliable delivery of healthcare products and services.

Why did AmerisourceBergen change its name to Cencora?

The name change to Cencora reflects the company's unified global presence and its commitment to creating healthier futures with a purpose-driven approach. It represents the company's vision and strategic growth in the healthcare sector.

What services does Cencora provide?

Cencora offers a wide range of services, including pharmaceutical distribution, specialty logistics, biopharma services, and market access solutions, ensuring that medications and healthcare products reach their destinations efficiently and safely.

What recent strategic investments has Cencora made?

Cencora has recently acquired OneOncology, a network of leading oncology practices, and PharmaLex, a regulatory consulting firm. These investments enhance Cencora's specialty services and global commercialization capabilities.

How does Cencora contribute to social responsibility?

Cencora is committed to social responsibility through initiatives like the Cencora Impact Foundation, which recently announced a $5 million donation to support global healthcare efforts, including a significant grant to the UNICEF Health Fund.

What is Cencora Ventures?

Cencora Ventures, formerly known as AB Health Ventures, is Cencora's corporate venture fund dedicated to advancing healthcare innovation. The fund supports startups and initiatives that align with Cencora's mission to improve healthcare access globally.

How large is Cencora's workforce?

Cencora employs over 46,000 team members worldwide, working across various segments of the pharmaceutical value chain to ensure the delivery of critical healthcare products and services.

What is Cencora's financial standing?

Cencora is a financial leader in the healthcare industry, with more than $200 billion in annual revenue. The company is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500.

When did Cencora begin trading under the new ticker symbol?

Cencora began trading under the new ticker symbol 'COR' on the New York Stock Exchange on August 30, 2023.

What is the purpose of the Cencora Healthier Futures Grant Program?

The Cencora Healthier Futures Grant Program, launched by the Cencora Impact Foundation, aims to support healthcare innovation and access for underserved populations. The inaugural grant of $500,000 was awarded to the UNICEF Health Fund.

AmerisourceBergen Corporation

NYSE:ABC

ABC Rankings

ABC Stock Data

36.15B
169.43M
16.68%
78.92%
3.5%
Medical Distribution
Healthcare
Link
United States
Conshohocken